GreenLight Biosciences Holdings, PBC Common Stock
GRNA
GRNA was delisted on the 21st of July, 2023.
70 hedge funds and large institutions have $163M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 8 closing their positions.
200% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 8
143% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 7
30% more funds holding
Funds holding: 54 → 70 (+16)
22% more capital invested
Capital invested by funds: $134M → $163M (+$29.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
+$6.91M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$6.5M |
| 3 |
OPU
Omni Partners US
Irvine,
California
|
+$6.16M |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$5.73M |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
+$4.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$30.4M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$12.9M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$4.66M |
| 4 |
Goldman Sachs
New York
|
-$3.27M |
| 5 |
CAC
Cowen and Company
New York
|
-$2.94M |
GRNA Hedge Fund Activity: Q3 2021 in Review
70 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q3 2021, worth a combined $163M — up 22% from $134M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new GRNA positions and 8 closed out — a net gain of 16 holders — while 17 added to existing stakes and 7 trimmed.
The largest buyer was Highbridge Capital Management, adding an estimated $6.91M. The largest seller was Hudson Bay Capital Management, cutting an estimated $30.4M.
- 70 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q3 2021, up from 54 in Q2 2021.
- Funds reported $163M of GreenLight Biosciences Holdings, PBC Common Stock stock for Q3 2021, up 22% quarter-over-quarter.
- 24 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q3 2021 and 8 closed out, a net change of +16 holders.
- The largest GreenLight Biosciences Holdings, PBC Common Stock buyer in Q3 2021 was Highbridge Capital Management, an estimated $6.91M added.
- The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q3 2021 was Hudson Bay Capital Management, an estimated $30.4M sold.
Based on aggregated 13F filings for Q3 2021.